[
  {
    "id": "Case10917",
    "patient_info": "The patient is an 8-week-old infant evaluated by a medical geneticist for persistent conjugated hyperbilirubinemia not attributed to total parenteral nutrition-associated cholestasis, and whole exome sequencing (WES) has been ordered to evaluate for an underlying genetic cause; family history is notable for an older sibling with multiple congenital anomalies, and Fragile X testing was previously performed and was nondiagnostic; pre-test counseling was completed with a genetic specialist and the family has coverage through UHC.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case8051",
    "patient_info": "An infant of 5 weeks with a major congenital cardiac anomaly is being evaluated with whole exome sequencing (WES) ordered by the family medicine physician, and prior fluorescence in situ hybridization testing was nondiagnostic; the history is notable for a mother with short stature raising concern for a growth-related genetic condition, the family completed pre-test genetic counseling and will follow up after results, and testing is being pursued to clarify the etiology of the cardiac defect and potential syndromic associations with billing through BCBS_FEP.",
    "expected_md5": "d5e9701c13de1dca302ad0ce45524039"
  },
  {
    "id": "Case11124",
    "patient_info": "An infant is presenting for evaluation of developmental delay and whole-exome sequencing (WES) has been ordered with coverage through UHC, following referral by an oncologist; pre-test counseling was completed and post-test genetic counseling is planned after results are returned. Prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for an older sibling who had significant hearing impairment diagnosed in childhood, which raises concern for a hereditary etiology and supports comprehensive exomic testing.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case7376",
    "patient_info": "The patient is a 73-year-old referred by a neurologist for evaluation of a major abnormality involving at least one organ system that remains unexplained, and whole exome sequencing (WES) has been ordered for diagnostic clarification. Prior fluorescent in situ hybridization testing was nondiagnostic. The patient reports that a sister had triple negative breast cancer, which raises concern for an underlying heritable predisposition. Pre-test counseling was completed with a genetic specialist and testing will proceed with coverage through UHC.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case10451",
    "patient_info": "The patient is a 10-year-old with moderate to severe intellectual disability diagnosed in childhood who was referred by neurology for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder; prior chromosomal microarray (CMA) testing was nondiagnostic. There is a family history of a sibling who had a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing. The neurologist placed the order, there is no documentation of prior genetic counseling, and testing will be pursued with coverage through UHC.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case19321",
    "patient_info": "The patient is a 1-year-old referred by a neurologist for evaluation of a complex neurodevelopmental disorder with features concerning for autism spectrum disorder, and whole exome sequencing (WES) is being pursued to investigate a possible genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. A maternal aunt is reported to have multiple congenital anomalies, pre-test genetic counseling was completed, and plans are in place for post-test follow-up, with coverage through UHC.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case9349",
    "patient_info": "The patient is a 5-year-old with a congenital cardiac anomaly affecting a single organ system who was referred by a cardiologist for genetic evaluation and whole exome sequencing (WES) because the family history raises concern for an inherited etiology, specifically a paternal uncle who experienced sudden unexplained death before age 35; prior fluorescence in situ hybridization testing was nondiagnostic, pre-test counseling was completed with a genetic counselor and plans for post-test follow-up are confirmed, and testing will be pursued with coverage through BCBS_FEP.",
    "expected_md5": "d5e9701c13de1dca302ad0ce45524039"
  },
  {
    "id": "Case10363",
    "patient_info": "The patient is a 7-year-old child with a congenital anomaly present since birth who was referred by the general practitioner for whole genome sequencing (WGS) after fluorescence in situ hybridization (FISH) testing was nondiagnostic. The family history is notable for a maternal aunt with pancreatic cancer and the family has coverage through UHC. The patient has been seen multiple times by a genetic counselor for pre-test counseling and plans for post-test follow-up are in place. WGS is being pursued to provide a comprehensive genomic evaluation given the longstanding congenital findings and prior nondiagnostic targeted testing.",
    "expected_md5": "4fadf6b3ca9d4d08131cb31365e3aa7d"
  },
  {
    "id": "Case4512",
    "patient_info": "The patient is a 21-year-old referred by the primary care physician for evaluation of a major congenital cardiac anomaly present since birth, and whole genome sequencing (WGS) is being pursued to identify a potential genetic etiology; there is a family history of a sibling who experienced a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing which raised concern for a heritable predisposition, and no prior genetic testing has been performed, pre-test counseling was completed with a genetic counselor and a post-test visit is planned with testing submitted with coverage through BCBS_FEP.",
    "expected_md5": "d5e9701c13de1dca302ad0ce45524039"
  },
  {
    "id": "Case18257",
    "patient_info": "The 64-year-old patient has a history of breast cancer diagnosed at age 50 or younger and is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, family history is notable for a sibling with short stature, the test was ordered by the patient's general practitioner, there is no documentation of prior genetic counseling, and coverage is through Cigna.",
    "expected_md5": "626eac4d60df057ea93ece78f8cc3dfc"
  }
]